Screening for 6- phosphogluconate dehydrogenase abnormalities in the blood of dermatological patients

The results of screening for 6-phosphogluconate dehydrogenase abnormalities in the blood of dermatological patients are reported. No differences were found between controls, psoriatics, psoriatics receiving methotrexate and a group of mixed patients. The results are discussed in relation to the effects of methotrexate on glucose-6-phosphate dehydrogenase.